Qutenza Kit
Product Images NDC 72512-930

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 21 technical images submitted to the FDA as part of the official labeling for Qutenza (NDC 72512-930). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Averitas Pharma Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 6

FDA Label Image

Figure 7

FDA Label Image

Image 001

FDA Label Image

Image 002

FDA Label Image

Image 003

FDA Label Image

Image 004

FDA Label Image

Image 005

FDA Label Image

Figure 2.3-1 (Image 01)

FDA Label Image

Figure 2.3-2 (Image 02)

FDA Label Image

Figure 2.3-3 (Image 03)

FDA Label Image

Figure 2.3-4 (Image 04)

FDA Label Image

Figure 2.3-5 (Image 05)

FDA Label Image

Structural Formula Of Capsaicin (Image 06)

FDA Label Image

Figure 2 (Image 07)

FDA Label Image

Figure 3 (Image 08)

Figure 3 (Image 08)
This appears to be a graph or chart of some kind, showing the proportion of patients who have responded to a treatment over the course of several weeks. The treatment may be related to controlling or reducing doses of something, but the specific nature of the treatment or condition is not clear. There are two percentage values shown, 100% and 0%, but it is not clear what they refer to. The note at the bottom suggests that not all patients may have responded in the same way at each time point. Overall, without additional context or information, it is difficult to provide a more detailed or useful description of this text.*
FDA Label Image

Figure 4 (Image 09)

FDA Label Image

Figure 5 (Image 10)

FDA Label Image

Averitas Pharma Logo (Image 11)

FDA Label Image

Small Image 12

Small Image 12
The text is a product label or packaging information for a topical system containing 8% capsaicin. It is likely a pain relief product, as capsaicin is known for its analgesic properties.*
FDA Label Image

Small Image 13

FDA Label Image

Small Image 14

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.